Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-20

Clinical Trial Update: A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the effect of QAW039 in non-atopic asthma; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QAW039

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2017-03-20